The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease. (Source: Health News from Medical News Today)
The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease. (Source: Health News from Medical News Today)
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
Only about half of P.E.I. pharmacies are carrying antiviral medications, in an effort by health officials to keep people sick with swine flu out of large crowds. (Source: CBC | Health)
Seven new cases of swine flu in one week have prompted the Newfoundland and Labrador government to make its stockpile of anti-viral medication to fight H1N1 influenza available to doctors. (Source: CBC | Health)
Four different influenza antiviral medications (amantadine, rimantadine, oseltamivir, and zanamivir) are approved by the U.S. Food and Drug Administration (FDA) for the treatment and/or prevention of influenza. All four usually work against influenza A viruses. However, the drugs may not always work, because influenza virus strains can become resistant to one or more of these medications. For example, the influenza A (H5N1) viruses identified in human in Asia in 2004 and 2005 have been resistant to amantadine and rimantadine. Monitoring of avian viruses for resistance to influenza antiviral medications continues.
CDC recommends the use of oseltamivir or zanamivir for the treatment or prevention of infection with swine influenza viruses. These medications must be prescribed by a health care professional.